Nrx Pharmaceuticals Inc (NRXP)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Nrx Pharmaceuticals Inc Azioni (NRXP) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2025-03-31	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	-	-	-	-	-
Income/Loss From Continuing Operations Before Tax	30.20% -5.512	-7.897	-6.528	-4.332	-6.062
Income Tax Expense/Benefit	-	-	-	-	-
Income/Loss From Continuing Operations After Tax	30.20% -5.512	-7.897	-6.528	-4.332	-6.062
Net Income/Loss	30.20% -5.512	-7.897	-6.528	-4.332	-6.062
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

SMMT

$20.66

2.36%

INCY

$84.81

1.10%

GMAB

$30.67

4.57%

BNTX

$98.62

0.53%

INSM

$144.01

1.67%

ONC

$340.70

2.36%